A published clinical trial found that 75% of chronic back pain patients became completely pain-free after just four weeks of a talk-based therapy — and the medical world has been quietly wrestling with what that means ever since.
Quick Take
- A randomized controlled trial published on PubMed found Pain Reprocessing Therapy eliminated pain in 75% of chronic back pain patients within one month.
- Dr. Howard Schubiner argues most chronic pain is neuroplastic — meaning the brain learned it and can unlearn it — not caused by structural damage.
- A second psychological treatment Schubiner co-developed, Emotional Awareness and Expression Therapy, outperformed cognitive behavioral therapy for fibromyalgia in a head-to-head trial.
- Critics note the diagnosis relies on ruling out structural causes rather than a confirmed biomarker, and independent replication outside Schubiner’s research network is still limited.
The Pain You Feel Is Real — But Where It Comes From May Surprise You
Every sensation you feel — heat, pressure, a stabbing ache in your lower back — is built inside your brain. That is not a philosophical claim. It is basic neuroscience. What Dr. Howard Schubiner, an internal medicine physician with 23 years of clinical experience, argues is that the brain can get stuck making pain even after the original injury is long gone. He calls this neuroplastic pain. The brain learned to fire a pain signal, and it keeps firing out of habit, not necessity.
This idea cuts against how most doctors are trained. Standard medical practice looks for a structural cause — a herniated disc, torn tissue, bone damage — and treats that. Schubiner’s framework says that approach misses a large group of patients entirely. He cites a striking data point: roughly 96% of people in their 80s show degenerative spinal changes on imaging, yet most feel no pain. If structural damage caused pain reliably, that number would not be possible.
What the Clinical Trials Actually Show
The strongest evidence behind Schubiner’s claims comes from a randomized controlled trial published in a peer-reviewed journal. Researchers tested Pain Reprocessing Therapy against placebo and standard care for chronic back pain. The result: 75% of patients in the therapy group became pain-free, and the results held up over time. A separate Harvard study Schubiner cites found that two-thirds of chronic low back pain patients eliminated their pain after roughly 2.5 months using the same approach. These are not small numbers. They are hard to dismiss.
Schubiner also co-developed a second treatment called Emotional Awareness and Expression Therapy, working alongside researchers including Mark Lumley and Tor Wager. In a head-to-head trial, that therapy outperformed cognitive behavioral therapy for fibromyalgia pain reduction. Two different treatments, two different conditions, two different trials — all pointing the same direction. That pattern matters when evaluating whether the results are a fluke.
Where the Science Has Gaps Worth Watching
The honest version of this story includes real limitations. Schubiner diagnoses neuroplastic pain by first ruling out structural causes through physical exams and lab work, then applying what he calls the FIT criteria — functional, inconsistent, and triggered. That diagnostic tool has not yet been validated in a published peer-reviewed study with sensitivity and specificity data against gold-standard imaging. That gap is not a reason to dismiss the treatment results, but it is a reason to want more research before the framework expands broadly.
The evidence also thins out considerably when moving beyond back pain and fibromyalgia. Schubiner claims conditions like chronic fatigue syndrome, long COVID, and postural orthostatic tachycardia syndrome are neuroplastic and reversible. A pilot study on long COVID showed promising signs of reversibility, but no large randomized controlled trial has validated Pain Reprocessing Therapy or Emotional Awareness and Expression Therapy for those conditions yet. The back pain results are solid. Extending them to every chronic condition requires more than clinical confidence — it requires trials.
What if chronic pain wasn’t just something to manage — but something that could change?
In Pain Reprocessing Therapy and the Neuroscience of Pain Reversal, Howard Schubiner, MD shares how PRT can help “turn off” pain at the brain level.
50% off! https://t.co/M7GrFRtHLA pic.twitter.com/KlkI1hEvLD
— NICABM (@nicabm) July 16, 2026
The Pushback and Why It Is Mostly Weak
Critics argue that brain-focused interventions typically yield only 10 to 20 percent improvement in disability measures — far below the 75% pain-free rate Schubiner’s trial reported. That is a real tension worth noting. But the counter-evidence does not directly re-analyze the Pain Reprocessing Therapy trial data or challenge its methodology with specifics. General skepticism about brain-based approaches is not the same as a forensic rebuttal of a published randomized controlled trial. Side B raises legitimate questions about mechanisms and generalizability, but it does not knock down the core finding.
One more thing deserves plain language: calling neuroplastic pain “all in your head” as a dismissal is scientifically illiterate. All pain is in your head. That is where the nervous system processes every signal your body sends. The question is whether the signal reflects ongoing tissue damage or a misfiring learned pattern. Schubiner’s work, whatever its remaining gaps, is asking the right question — and the early answers from controlled trials are too significant to ignore while we wait for perfect evidence.
Sources:
youtube.com, pmc.ncbi.nlm.nih.gov
